Form 4: Viking Therapeutics COO Sells Shares
Insider Transaction (Form 4)
Marianna Mancini, Chief Operating Officer of Viking Therapeutics, Inc., sold 18,217 shares of common stock on July 28, 2026 for $33.47 per share.
Summary
- Grant/award: acquired 31,667 Common Stock, par value $0.00001 per share on July 28, 2026; holds 440,977 after (Direct).
- Open-market sale: disposed of 18,217 Common Stock, par value $0.00001 per share at $33.47 ($609,636) on July 29, 2026; holds 422,760 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $609,636 of stock on the open market.
Insider Transactions
Marianna Mancini — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Grant/award | Common Stock, par value $0.00001 per share | 31,667 | — | — | 440,977 |
| 2026-07-29 | Open-market sale | Common Stock, par value $0.00001 per share | 18,217 | $33 | $609.6K | 422,760 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Grant/award (31,667 shares) |
| 2026-07-29 | Open-market sale (18,217 shares) |
Keywords
insider transaction, Form 4, VKTX, Viking Therapeutics, Inc., bearish, Marianna Mancini
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.